Jan 09, 2024 / 12:30AM GMT
Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst
Perfect. Good afternoon, everyone. This is Rachel Vatnsdal with the Life Science Tools and Diagnostics team at JPMorgan. We are here joined by Udit Batra, CEO of Waters. So this session will be as standard as you've seen earlier today, 20 minutes of presentation followed by 20 minutes of Q&A. (Operator Instructions)
And with that, Udit, I will let you take over. Thank you.
Udit Batra - Waters Corporation - President, CEO & Director
Thank you, Rachel. Good afternoon, everyone. Thank you for taking the time for one of these last slots in the afternoon. Appreciate your interest. 2023 started with us having a lot of positivity in our business and in the markets. And little did we know, in Q1, biotech came to a screeching halt. The macroeconomic conditions made our customers slow down their purchasing cycles. And of course, in China, we saw an unprecedented economic slowdown. And despite all of this, for the first 9 months of the year, we've delivered really, really
Waters Corp at JPMorgan Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers